前立腺がん治療の世界市場 2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Prostate Cancer Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D005-00839 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、前立腺がん治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。前立腺がん治療の種類別市場規模（生物学的療法、化学療法）、用途別市場規模（病院、研究機関、クリニック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Tolmar、Ipsen、Ferring Pharmaceuticals、Astellas Pharma、Sanofi、AstraZeneca、Bayer、Abbott、Johnson & Johnson、Novartis ・地域別グローバル市場分析 2015年-2020年 ・前立腺がん治療の北米市場（アメリカ、カナダ、メキシコ） ・前立腺がん治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・前立腺がん治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・前立腺がん治療の南米市場（ブラジル、アルゼンチン） ・前立腺がん治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：生物学的療法、化学療法 ・用途別分析：病院、研究機関、クリニック ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論

Market Overview
The global Prostate Cancer Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Prostate Cancer Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Prostate Cancer Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Prostate Cancer Treatment market has been segmented into:
Biological Therapy
Chemotherapy

By Application, Prostate Cancer Treatment has been segmented into:
Hospital
Research Institution
Clinic

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Prostate Cancer Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Prostate Cancer Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Prostate Cancer Treatment market.

The report offers in-depth assessment of the growth and other aspects of the Prostate Cancer Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Prostate Cancer Treatment Market Share Analysis
Prostate Cancer Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Prostate Cancer Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Prostate Cancer Treatment sales, revenue and market share for each player covered in this report.

The major players covered in Prostate Cancer Treatment are:
Tolmar
Ipsen
Ferring Pharmaceuticals
Astellas Pharma
Sanofi
AstraZeneca
Bayer
Abbott
Johnson & Johnson
Novartis

レポート目次

---

Table of Contents

1 Prostate Cancer Treatment Market Overview
1.1 Product Overview and Scope of Prostate Cancer Treatment
1.2 Classification of Prostate Cancer Treatment by Type
1.2.1 Global Prostate Cancer Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Prostate Cancer Treatment Revenue Market Share by Type in 2019
1.2.3 Biological Therapy
1.2.4 Chemotherapy
1.3 Global Prostate Cancer Treatment Market by Application
1.3.1 Overview: Global Prostate Cancer Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Research Institution
1.3.4 Clinic
1.4 Global Prostate Cancer Treatment Market by Regions
1.4.1 Global Prostate Cancer Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Prostate Cancer Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Prostate Cancer Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Prostate Cancer Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Prostate Cancer Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Prostate Cancer Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Prostate Cancer Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Tolmar
2.1.1 Tolmar Details
2.1.2 Tolmar Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Tolmar SWOT Analysis
2.1.4 Tolmar Product and Services
2.1.5 Tolmar Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Ipsen
2.2.1 Ipsen Details
2.2.2 Ipsen Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Ipsen SWOT Analysis
2.2.4 Ipsen Product and Services
2.2.5 Ipsen Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Ferring Pharmaceuticals
2.3.1 Ferring Pharmaceuticals Details
2.3.2 Ferring Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Ferring Pharmaceuticals SWOT Analysis
2.3.4 Ferring Pharmaceuticals Product and Services
2.3.5 Ferring Pharmaceuticals Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Astellas Pharma
2.4.1 Astellas Pharma Details
2.4.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Astellas Pharma SWOT Analysis
2.4.4 Astellas Pharma Product and Services
2.4.5 Astellas Pharma Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sanofi SWOT Analysis
2.5.4 Sanofi Product and Services
2.5.5 Sanofi Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 AstraZeneca SWOT Analysis
2.6.4 AstraZeneca Product and Services
2.6.5 AstraZeneca Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Bayer
2.7.1 Bayer Details
2.7.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Bayer SWOT Analysis
2.7.4 Bayer Product and Services
2.7.5 Bayer Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Abbott
2.8.1 Abbott Details
2.8.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Abbott SWOT Analysis
2.8.4 Abbott Product and Services
2.8.5 Abbott Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Johnson & Johnson
2.9.1 Johnson & Johnson Details
2.9.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Johnson & Johnson SWOT Analysis
2.9.4 Johnson & Johnson Product and Services
2.9.5 Johnson & Johnson Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Novartis SWOT Analysis
2.10.4 Novartis Product and Services
2.10.5 Novartis Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Prostate Cancer Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Prostate Cancer Treatment Players Market Share
3.2.2 Top 10 Prostate Cancer Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Prostate Cancer Treatment Revenue and Market Share by Regions
4.2 North America Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
5 North America Prostate Cancer Treatment Revenue by Countries
5.1 North America Prostate Cancer Treatment Revenue by Countries (2015-2020)
5.2 USA Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
6 Europe Prostate Cancer Treatment Revenue by Countries
6.1 Europe Prostate Cancer Treatment Revenue by Countries (2015-2020)
6.2 Germany Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
6.4 France Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Prostate Cancer Treatment Revenue by Countries
7.1 Asia-Pacific Prostate Cancer Treatment Revenue by Countries (2015-2020)
7.2 China Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
7.5 India Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
8 South America Prostate Cancer Treatment Revenue by Countries
8.1 South America Prostate Cancer Treatment Revenue by Countries (2015-2020)
8.2 Brazil Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Prostate Cancer Treatment by Countries
9.1 Middle East & Africa Prostate Cancer Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Prostate Cancer Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Prostate Cancer Treatment Market Forecast by Type (2019-2024)
10.3 Biological Therapy Revenue Growth Rate (2015-2025)
10.4 Chemotherapy Revenue Growth Rate (2015-2025)
11 Global Prostate Cancer Treatment Market Segment by Application
11.1 Global Prostate Cancer Treatment Revenue Market Share by Application (2015-2020)
11.2 Prostate Cancer Treatment Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Research Institution Revenue Growth (2015-2020)
11.5 Clinic Revenue Growth (2015-2020)
12 Global Prostate Cancer Treatment Market Size Forecast (2021-2025)
12.1 Global Prostate Cancer Treatment Market Size Forecast (2021-2025)
12.2 Global Prostate Cancer Treatment Market Forecast by Regions (2021-2025)
12.3 North America Prostate Cancer Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Prostate Cancer Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Prostate Cancer Treatment Revenue Market Forecast (2021-2025)
12.6 South America Prostate Cancer Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Prostate Cancer Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Prostate Cancer Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Prostate Cancer Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Prostate Cancer Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Prostate Cancer Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Tolmar Corporate Information, Location and Competitors
Table 6. Tolmar Prostate Cancer Treatment Major Business
Table 7. Tolmar Prostate Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Tolmar SWOT Analysis
Table 9. Tolmar Prostate Cancer Treatment Product and Solutions
Table 10. Tolmar Prostate Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Ipsen Corporate Information, Location and Competitors
Table 12. Ipsen Prostate Cancer Treatment Major Business
Table 13. Ipsen Prostate Cancer Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Ipsen SWOT Analysis
Table 15. Ipsen Prostate Cancer Treatment Product and Solutions
Table 16. Ipsen Prostate Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Ferring Pharmaceuticals Corporate Information, Location and Competitors
Table 18. Ferring Pharmaceuticals Prostate Cancer Treatment Major Business
Table 19. Ferring Pharmaceuticals Prostate Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Ferring Pharmaceuticals SWOT Analysis
Table 21. Ferring Pharmaceuticals Prostate Cancer Treatment Product and Solutions
Table 22. Ferring Pharmaceuticals Prostate Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Astellas Pharma Corporate Information, Location and Competitors
Table 24. Astellas Pharma Prostate Cancer Treatment Major Business
Table 25. Astellas Pharma Prostate Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Astellas Pharma SWOT Analysis
Table 27. Astellas Pharma Prostate Cancer Treatment Product and Solutions
Table 28. Astellas Pharma Prostate Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Sanofi Corporate Information, Location and Competitors
Table 30. Sanofi Prostate Cancer Treatment Major Business
Table 31. Sanofi Prostate Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Sanofi SWOT Analysis
Table 33. Sanofi Prostate Cancer Treatment Product and Solutions
Table 34. Sanofi Prostate Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. AstraZeneca Corporate Information, Location and Competitors
Table 36. AstraZeneca Prostate Cancer Treatment Major Business
Table 37. AstraZeneca Prostate Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 38. AstraZeneca SWOT Analysis
Table 39. AstraZeneca Prostate Cancer Treatment Product and Solutions
Table 40. AstraZeneca Prostate Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Bayer Corporate Information, Location and Competitors
Table 42. Bayer Prostate Cancer Treatment Major Business
Table 43. Bayer Prostate Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Bayer SWOT Analysis
Table 45. Bayer Prostate Cancer Treatment Product and Solutions
Table 46. Bayer Prostate Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Abbott Corporate Information, Location and Competitors
Table 48. Abbott Prostate Cancer Treatment Major Business
Table 49. Abbott Prostate Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 50. Abbott SWOT Analysis
Table 51. Abbott Prostate Cancer Treatment Product and Solutions
Table 52. Abbott Prostate Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Johnson & Johnson Corporate Information, Location and Competitors
Table 54. Johnson & Johnson Prostate Cancer Treatment Major Business
Table 55. Johnson & Johnson Prostate Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 56. Johnson & Johnson SWOT Analysis
Table 57. Johnson & Johnson Prostate Cancer Treatment Product and Solutions
Table 58. Johnson & Johnson Prostate Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Novartis Corporate Information, Location and Competitors
Table 60. Novartis Prostate Cancer Treatment Major Business
Table 61. Novartis Prostate Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 62. Novartis SWOT Analysis
Table 63. Novartis Prostate Cancer Treatment Product and Solutions
Table 64. Novartis Prostate Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Prostate Cancer Treatment Revenue (Million USD) by Players (2015-2020)
Table 66. Global Prostate Cancer Treatment Revenue Share by Players (2015-2020)
Table 67. Global Prostate Cancer Treatment Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Prostate Cancer Treatment Revenue Market Share by Regions (2015-2020)
Table 69. North America Prostate Cancer Treatment Revenue by Countries (2015-2020)
Table 70. North America Prostate Cancer Treatment Revenue Market Share by Countries (2015-2020)
Table 71. Europe Prostate Cancer Treatment Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Prostate Cancer Treatment Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Prostate Cancer Treatment Revenue by Countries (2015-2020)
Table 74. South America Prostate Cancer Treatment Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Prostate Cancer Treatment Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Prostate Cancer Treatment Revenue Market Share by Countries (2015-2020)
Table 77. Global Prostate Cancer Treatment Revenue (Million USD) by Type (2015-2020)
Table 78. Global Prostate Cancer Treatment Revenue Share by Type (2015-2020)
Table 79. Global Prostate Cancer Treatment Revenue Forecast by Type (2021-2025)
Table 80. Global Prostate Cancer Treatment Revenue by Application (2015-2020)
Table 81. Global Prostate Cancer Treatment Revenue Share by Application (2015-2020)
Table 82. Global Prostate Cancer Treatment Revenue Forecast by Application (2021-2025)
Table 83. Global Prostate Cancer Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Prostate Cancer Treatment Picture
Figure 2. Global Prostate Cancer Treatment Revenue Market Share by Type in 2019
Figure 3. Biological Therapy Picture
Figure 4. Chemotherapy Picture
Figure 5. Prostate Cancer Treatment Revenue Market Share by Application in 2019
Figure 6. Hospital Picture
Figure 7. Research Institution Picture
Figure 8. Clinic Picture
Figure 9. Global Prostate Cancer Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Prostate Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Prostate Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Prostate Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Prostate Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Prostate Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Prostate Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Prostate Cancer Treatment Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Prostate Cancer Treatment Revenue Market Share in 2019
Figure 18. Global Top 10 Players Prostate Cancer Treatment Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Prostate Cancer Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Prostate Cancer Treatment Revenue Market Share by Regions (2015-2020)
Figure 22. Global Prostate Cancer Treatment Revenue Market Share by Regions in 2018
Figure 23. North America Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 24. Europe Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 26. South America Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 28. North America Prostate Cancer Treatment Revenue Market Share by Countries (2015-2020)
Figure 29. North America Prostate Cancer Treatment Revenue Market Share by Countries in 2019
Figure 30. USA Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 31. Canada Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Europe Prostate Cancer Treatment Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Prostate Cancer Treatment Revenue Market Share by Countries in 2019
Figure 35. Germany Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 36. UK Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 37. France Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 38. Russia Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Italy Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Prostate Cancer Treatment Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Prostate Cancer Treatment Revenue Market Share by Countries in 2019
Figure 42. China Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Japan Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Korea Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 45. India Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 47. South America Prostate Cancer Treatment Revenue Market Share by Countries (2015-2020)
Figure 48. South America Prostate Cancer Treatment Revenue Market Share by Countries in 2019
Figure 49. Brazil Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Prostate Cancer Treatment Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Prostate Cancer Treatment Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 54. UAE Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Prostate Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 57. Global Prostate Cancer Treatment Revenue Share by Type (2015-2020)
Figure 58. Global Prostate Cancer Treatment Revenue Share by Type in 2019
Figure 59. Global Prostate Cancer Treatment Market Share Forecast by Type (2021-2025)
Figure 60. Global Biological Therapy Revenue Growth Rate (2015-2020)
Figure 61. Global Chemotherapy Revenue Growth Rate (2015-2020)
Figure 62. Global Prostate Cancer Treatment Revenue Share by Application (2015-2020)
Figure 63. Global Prostate Cancer Treatment Revenue Share by Application in 2019
Figure 64. Global Prostate Cancer Treatment Market Share Forecast by Application (2021-2025)
Figure 65. Global Hospital Revenue Growth Rate (2015-2020)
Figure 66. Global Research Institution Revenue Growth Rate (2015-2020)
Figure 67. Global Clinic Revenue Growth Rate (2015-2020)
Figure 68. Global Prostate Cancer Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Prostate Cancer Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Prostate Cancer Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Prostate Cancer Treatment Revenue Market Forecast (2021-2025)
Figure 72. Europe Prostate Cancer Treatment Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Prostate Cancer Treatment Revenue Market Forecast (2021-2025)
Figure 74. South America Prostate Cancer Treatment Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Prostate Cancer Treatment Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel

---